1-5 of 5
David Vilanova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessment of Clinical Differences Between Starting Antimyeloma Treatment at Biological Relapse or at Clinical Relapse: Preliminary Results of an Observational Prospective Registry

Mercedes Gironella, Juan Bergua, Carlos Fernández de Larrea, Fernando Escalante, Maria González, Carmen Martínez Chamorro, Aurelio López, E Pérez-Persona, Juan José Lahuerta, Nieves Somilinos, Alfonso Soler, Yolanda Gonzalez, Alexia Suárez Cabrera, Abelardo Barez, Valentin Cabañas, Antonia Sampol, Ana Pilar Gonzalez, Giselle Lostaunau, David Vilanova, Adrian Alegre
Journal: Blood
Blood (2015) 126 (23): 4231.
https://doi.org/10.1182/blood.V126.23.4231.4231
Published: 2015
Journal Articles

Observational Prospective Registry for the Assessment of the Clinical Impact of Starting Anti-Myeloma Treatment at Biological Relapse

Adrian Alegre, Merche Gironella, Juan Miguel Bergua, Esther Gonzalez, Fernando Escalante, Alfon Soler, Antonia Sampol, Ana Pilar Gonzalez, Valentin Cabañas, Juan Jose Lahuerta, Aurelio Lopez, Ana Dios, Abelardo Bárez, Antonio Ruiz, David Vilanova, Joaquín Díaz-Mediavilla
Journal: Blood
Blood (2014) 124 (21): 4765.
https://doi.org/10.1182/blood.V124.21.4765.4765
Published: 2014
Journal Articles

Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks

Enrique M. Ocio, Patricia Maiso, Xi Chen, Mercedes Garayoa, Stela Álvarez-Fernández, Laura San-Segundo, David Vilanova, Lucía López-Corral, Juan C. Montero, Teresa Hernández-Iglesias, Enrique de Álava, Carlos Galmarini, Pablo Avilés, Carmen Cuevas, Jesús F. San-Miguel, Atanasio Pandiella
Journal: Blood
Blood (2009) 113 (16): 3781–3791.
https://doi.org/10.1182/blood-2008-09-177774
Published: 2009
Includes: Supplemental data
Journal Articles

DNA Double Strand Breaks Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity

Enrique M Ocio, Patricia Maiso, Xi Chen, Mercedes Garayoa, Stela Álvarez-Fernández, Laura San-Segundo, David Vilanova, Lucía López-Corral, Juan Carlos Montero, Teresa Hernández-Iglesias, Enrique de Álava, Carlos Galmarini, Pablo Avilés, Carmen Cuevas, Atanasio Pandiella, J.F. San Miguel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 245.
https://doi.org/10.1182/blood.V112.11.245.245
Published: 2008
Journal Articles

Triple Combinations of the HDAC Inhibitor Panobinostat (LBH589) + Dexamethasone with Either Lenalidomide or Bortezomib Are Highly Effective in a Multiple Myeloma Mouse Model.

Enrique M. Ocio, MD, PhD, David Vilanova, BS, Laura San-Segundo, BS, Patricia Maiso, BS, PhD, Mercedes Garayoa, BS, PhD, Peter Atadja, Atanasio Pandiella, MD, PhD, J.F. San Miguel, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1514.
https://doi.org/10.1182/blood.V110.11.1514.1514
Published: 2007